FIG. 2.

Drugs which alter MT stability affect the localization of VP22. Untransfected (mock) and VP22-expressing (transfected) COS-1 cells were incubated in either nocodazole (10 μg/ml) (A) or taxol (50 μg/ml) (B) for 3 h prior to fixation. Cells were stained with AGV30 and/or anti-α-tubulin. VP22-expressing cells are arrowed.